| 42-day mortality | One-year mortality | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Model 1a | Model 2b | Model 3a | Model 4b | ||||||||
 | HR | 95 % CI | P value | HR | 95 % CI | P value | HR | 95 % CI | P value | HR | 95 % CI | P value |
All patients | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Non-DM & CKD | Ref. |  |  |  |  |  | Ref. |  |  |  |  |  |
 Only DM | 0.72 | 0.50–1.02 | 0.062 |  |  |  | 0.80 | 0.64–1.02 | 0.066 |  |  |  |
 Only CKD | 1.25 | 0.62–2.52 | 0.541 |  |  |  | 1.07 | 0.65–1.76 | 0.801 |  |  |  |
 DM + CKD | 1.99 | 1.03–3.84 | 0.042 |  |  |  | 1.84 | 1.14–2.98 | 0.012 |  |  |  |
P for DM × CKD interaction | 0.100 |  |  |  |  | 0.028 |  |  |  | |||
Women | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | ||
 Non-DM & CKD |  |  | Ref. |  |  |  |  | Ref. |  |  | ||
 Only DM |  |  | 1.11 | 0.56–2.21 | 0.772 |  |  | 0.77 | 0.49–1.21 | 0.260 | ||
 Only CKD |  |  | 3.40 | 0.75–15.48 | 0.113 |  |  | 1.30 | 0.39–4.28 | 0.672 | ||
 DM + CKD |  |  | 4.03 | 1.40–11.59 | 0.010 |  |  | 2.84 | 1.31–6.14 | 0.008 | ||
Men | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | ||
 Non-DM & CKD |  |  | 2.00 | 1.14–3.52 | 0.016 |  |  | 1.61 | 1.13–2.29 | 0.009 | ||
 Only DM |  |  | 1.25 | 0.67–2.32 | 0.487 |  |  | 1.32 | 0.90–1.92 | 0.154 | ||
 Only CKD |  |  | 2.02 | 0.83–4.94 | 0.123 |  |  | 1.64 | 0.90–2.98 | 0.108 | ||
 DM + CKD |  |  | 2.93 | 1.14–7.57 | 0.026 |  |  | 2.42 | 1.28–4.57 | 0.007 | ||
P for gender × diseases interaction |  |  | 0.920 |  |  | 0.559 |